Healthcare -
Biotechnology - NASDAQ - US
$ 9.02
2.85 %
$ 446 M
Market Cap
-2.45
P/E
KALV - TOTAL LIABILITIES
Total Liabilities KALV - KalVista Pharmaceuticals, Inc.
28.8 M
LAST VALUE
23.86%
2 YEAR CAGR
6.14%
5 YEAR CAGR
-4.10%
10 YEAR CAGR